A small phase I study (NCT03017820) examining the safety and efficacy of oncolytic viral therapy in patients with relapsed or refractory hematological malignancies has shown impressive results, with remission of lymphoma seen following a single dose of vesicular stomatitis virus, interferon-β with sodium iodide symporter [38]. This evidence concerns the gene SLC5A5 and hematologic disorder.